179 related articles for article (PubMed ID: 26826411)
21. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.
Park JH; Lee C; Suh JH; Chae JY; Kim HW; Moon KC
Hum Pathol; 2015 Mar; 46(3):454-60. PubMed ID: 25628030
[TBL] [Abstract][Full Text] [Related]
22. An Integrative Morphomolecular Classification System of Gastric Carcinoma With Distinct Clinical Outcomes.
Tsai JH; Jeng YM; Chen KH; Lee CH; Yuan CT; Liau JY
Am J Surg Pathol; 2020 Aug; 44(8):1017-1030. PubMed ID: 32568823
[TBL] [Abstract][Full Text] [Related]
23. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
[TBL] [Abstract][Full Text] [Related]
24. Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patients.
Tober JM; Halske C; Behrens HM; Krüger S; Röcken C
Hum Pathol; 2019 Dec; 94():98-109. PubMed ID: 31704366
[TBL] [Abstract][Full Text] [Related]
25. Activation of FOXO3a suggests good prognosis of patients with radically resected gastric cancer.
Yu S; Yu Y; Sun Y; Wang X; Luo R; Zhao N; Zhang W; Li Q; Cui Y; Wang Y; Li W; Liu T
Int J Clin Exp Pathol; 2015; 8(3):2963-70. PubMed ID: 26045805
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
Gonzalez RS; Messing S; Tu X; McMahon LA; Whitney-Miller CL
Hum Pathol; 2016 Oct; 56():16-21. PubMed ID: 27342907
[TBL] [Abstract][Full Text] [Related]
27. Morphological Features and Prognostic Significance of ARID1A-Deficient Esophageal Adenocarcinomas.
Drage MG; Tippayawong M; Agoston AT; Zheng Y; Bueno R; Hornick JL; Odze RD; Srivastava A
Arch Pathol Lab Med; 2017 Jul; 141(7):970-977. PubMed ID: 28440661
[TBL] [Abstract][Full Text] [Related]
28. Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma.
Ahadi M; Andrici J; Sioson L; Sheen A; Clarkson A; Gill AJ
Hum Pathol; 2016 Nov; 57():91-97. PubMed ID: 27476040
[TBL] [Abstract][Full Text] [Related]
29. High Ki67 Expression has Prognostic Value in Surgically-Resected T3 Gastric Adenocarcinoma.
Huang G; Chen S; Wang D; Wang R; Lin L; Chen S; Wang L; Huang Q
Clin Lab; 2016; 62(1-2):141-53. PubMed ID: 27012044
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological significance of SIRT1 and p300/CBP expression in gastroesophageal junction (GEJ) cancer and the correlation with E-cadherin and MLH1.
Zhang LH; Huang Q; Fan XS; Wu HY; Yang J; Feng AN
Pathol Res Pract; 2013 Oct; 209(10):611-7. PubMed ID: 24035280
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
33. STAT3 expression in gastric cancer indicates a poor prognosis.
Kim DY; Cha ST; Ahn DH; Kang HY; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS; Hong SP
J Gastroenterol Hepatol; 2009 Apr; 24(4):646-51. PubMed ID: 19175826
[TBL] [Abstract][Full Text] [Related]
34. Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer.
Eo WK; Jeong DW; Chang HJ; Won KY; Choi SI; Kim SH; Chun SW; Oh YL; Lee TH; Kim YO; Kim KH; Ji YI; Kim A; Kim HY
World J Gastroenterol; 2015 Mar; 21(9):2668-76. PubMed ID: 25759535
[TBL] [Abstract][Full Text] [Related]
35. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
36. DOK2 as a marker of poor prognosis of patients with gastric adenocarcinoma after curative resection.
Miyagaki H; Yamasaki M; Takahashi T; Kurokawa Y; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
Ann Surg Oncol; 2012 May; 19(5):1560-7. PubMed ID: 22130622
[TBL] [Abstract][Full Text] [Related]
37. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.
Singhi AD; Foxwell TJ; Nason K; Cressman KL; McGrath KM; Sun W; Bahary N; Zeh HJ; Levy RM; Luketich JD; Davison JM
Am J Surg Pathol; 2015 Apr; 39(4):487-95. PubMed ID: 25634752
[TBL] [Abstract][Full Text] [Related]
38. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.
Hur H; Kim YB; Ham IH; Lee D
J Surg Oncol; 2015 Nov; 112(6):585-91. PubMed ID: 26381042
[TBL] [Abstract][Full Text] [Related]
39. Nuclear overexpression of the overexpressed in lung cancer 1 predicts worse prognosis in gastric adenocarcinoma.
Wang J; Shen H; Fu G; Zhao D; Wang W
Oncotarget; 2017 Feb; 8(6):9442-9450. PubMed ID: 28038462
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic and prognostic values of repair protein hMLH1, hMSH2 and protein CD34 immunoexpression in sporadic colorectal cancer].
Słomka M; Stasikowska O; Wagrowska-Danilewicz M; Danilewicz M; Małecka-Panas E
Pol Merkur Lekarski; 2010 Dec; 29(174):351-6. PubMed ID: 21298983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
